Global Rabies Vaccine Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 96
Inquire Before Buying

Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.

Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.

Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.

The global Rabies Vaccine market is valued at 836.9 million US$ in 2020 is expected to reach 1104.7 million US$ by the end of 2026, growing at a CAGR of 4.0% during 2021-2026.

This report focuses on Rabies Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Rabies Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Rabies Vaccine market is segmented into

- Vero Cell Rabies Vaccine

- BHK

- Chick Embryo Cell Rabies Vaccine

- Other

Segment by Application

- Pre-exposure Prophylaxis

- Post-exposure Prophylaxis

Global Rabies Vaccine Market: Regional Analysis

The Rabies Vaccine market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Rabies Vaccine market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Rabies Vaccine Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Rabies Vaccine market include:

- GSK (Novartis)

- Sanofi-Pasteur

- Chengda

- Yisheng

- Prcmise

- VACN

- Changsheng

- BCHT

- Hissen

Global Rabies Vaccine Market Research Report 2020

Table of Contents
1 Rabies Vaccine Market Overview
1.1 Product Overview and Scope of Rabies Vaccine
1.2 Rabies Vaccine Segment by Type
1.2.1 Global Rabies Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Other
1.3 Rabies Vaccine Segment by Application
1.3.1 Rabies Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 Pre-exposure Prophylaxis
1.3.3 Post-exposure Prophylaxis
1.4 Global Rabies Vaccine Market Size Estimates and Forecasts
1.4.1 Global Rabies Vaccine Revenue 2015-2026
1.4.2 Global Rabies Vaccine Sales 2015-2026
1.4.3 Rabies Vaccine Market Size by Region: 2020 Versus 2026
2 Global Rabies Vaccine Market Competition by Manufacturers
2.1 Global Rabies Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Rabies Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Rabies Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Rabies Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Rabies Vaccine Market Competitive Situation and Trends
2.5.1 Rabies Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Rabies Vaccine Players (Opinion Leaders)
3 Rabies Vaccine Retrospective Market Scenario by Region
3.1 Global Rabies Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Rabies Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Rabies Vaccine Market Facts & Figures by Country
3.3.1 North America Rabies Vaccine Sales by Country
3.3.2 North America Rabies Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Rabies Vaccine Market Facts & Figures by Country
3.4.1 Europe Rabies Vaccine Sales by Country
3.4.2 Europe Rabies Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Rabies Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Rabies Vaccine Sales by Region
3.5.2 Asia Pacific Rabies Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Rabies Vaccine Market Facts & Figures by Country
3.6.1 Latin America Rabies Vaccine Sales by Country
3.6.2 Latin America Rabies Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Rabies Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Rabies Vaccine Sales by Country
3.7.2 Middle East and Africa Rabies Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Rabies Vaccine Historic Market Analysis by Type
4.1 Global Rabies Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Rabies Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Rabies Vaccine Price Market Share by Type (2015-2020)
4.4 Global Rabies Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Rabies Vaccine Historic Market Analysis by Application
5.1 Global Rabies Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Rabies Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Rabies Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Rabies Vaccine Business
6.1 GSK (Novartis)
6.1.1 Corporation Information
6.1.2 GSK (Novartis) Description, Business Overview and Total Revenue
6.1.3 GSK (Novartis) Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK (Novartis) Products Offered
6.1.5 GSK (Novartis) Recent Development
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Rabies Vaccine Production Sites and Area Served
6.2.2 Sanofi-Pasteur Description, Business Overview and Total Revenue
6.2.3 Sanofi-Pasteur Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi-Pasteur Products Offered
6.2.5 Sanofi-Pasteur Recent Development
6.3 Chengda
6.3.1 Chengda Rabies Vaccine Production Sites and Area Served
6.3.2 Chengda Description, Business Overview and Total Revenue
6.3.3 Chengda Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Chengda Products Offered
6.3.5 Chengda Recent Development
6.4 Yisheng
6.4.1 Yisheng Rabies Vaccine Production Sites and Area Served
6.4.2 Yisheng Description, Business Overview and Total Revenue
6.4.3 Yisheng Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Yisheng Products Offered
6.4.5 Yisheng Recent Development
6.5 Prcmise
6.5.1 Prcmise Rabies Vaccine Production Sites and Area Served
6.5.2 Prcmise Description, Business Overview and Total Revenue
6.5.3 Prcmise Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Prcmise Products Offered
6.5.5 Prcmise Recent Development
6.6 VACN
6.6.1 VACN Rabies Vaccine Production Sites and Area Served
6.6.2 VACN Description, Business Overview and Total Revenue
6.6.3 VACN Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 VACN Products Offered
6.6.5 VACN Recent Development
6.7 Changsheng
6.6.1 Changsheng Rabies Vaccine Production Sites and Area Served
6.6.2 Changsheng Description, Business Overview and Total Revenue
6.6.3 Changsheng Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Changsheng Products Offered
6.7.5 Changsheng Recent Development
6.8 BCHT
6.8.1 BCHT Rabies Vaccine Production Sites and Area Served
6.8.2 BCHT Description, Business Overview and Total Revenue
6.8.3 BCHT Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.8.4 BCHT Products Offered
6.8.5 BCHT Recent Development
6.9 Hissen
6.9.1 Hissen Rabies Vaccine Production Sites and Area Served
6.9.2 Hissen Description, Business Overview and Total Revenue
6.9.3 Hissen Rabies Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Hissen Products Offered
6.9.5 Hissen Recent Development
7 Rabies Vaccine Manufacturing Cost Analysis
7.1 Rabies Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Rabies Vaccine
7.4 Rabies Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Rabies Vaccine Distributors List
8.3 Rabies Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Rabies Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Rabies Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Rabies Vaccine by Type (2021-2026)
10.2 Rabies Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Rabies Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Rabies Vaccine by Application (2021-2026)
10.3 Rabies Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Rabies Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Rabies Vaccine by Region (2021-2026)
10.4 North America Rabies Vaccine Estimates and Projections (2021-2026)
10.5 Europe Rabies Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Rabies Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Rabies Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Rabies Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Rabies Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Rabies Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Rabies Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Rabies Vaccine Manufacturers Covered in This Study
Table 5. Global Rabies Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Rabies Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Rabies Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Rabies Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Rabies Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Rabies Vaccine Sales Sites and Area Served
Table 11. Manufacturers Rabies Vaccine Product Types
Table 12. Global Rabies Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Rabies Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rabies Vaccine as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Rabies Vaccine Players
Table 16. Global Rabies Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Rabies Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Rabies Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Rabies Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Rabies Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Rabies Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Rabies Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Rabies Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Rabies Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Rabies Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Rabies Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Rabies Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Rabies Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Rabies Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Rabies Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Rabies Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Rabies Vaccine Sales Share by Type (2015-2020)
Table 42. Global Rabies Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Rabies Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Rabies Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Rabies Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Rabies Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Rabies Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GSK (Novartis) Rabies Vaccine Corporation Information
Table 49. GSK (Novartis) Description and Business Overview
Table 50. GSK (Novartis) Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GSK (Novartis) Main Product
Table 52. GSK (Novartis) Recent Development
Table 53. Sanofi-Pasteur Rabies Vaccine Corporation Information
Table 54. Sanofi-Pasteur Corporation Information
Table 55. Sanofi-Pasteur Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi-Pasteur Main Product
Table 57. Sanofi-Pasteur Recent Development
Table 58. Chengda Rabies Vaccine Corporation Information
Table 59. Chengda Corporation Information
Table 60. Chengda Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Chengda Main Product
Table 62. Chengda Recent Development
Table 63. Yisheng Rabies Vaccine Corporation Information
Table 64. Yisheng Corporation Information
Table 65. Yisheng Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Yisheng Main Product
Table 67. Yisheng Recent Development
Table 68. Prcmise Rabies Vaccine Corporation Information
Table 69. Prcmise Corporation Information
Table 70. Prcmise Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Prcmise Main Product
Table 72. Prcmise Recent Development
Table 73. VACN Rabies Vaccine Corporation Information
Table 74. VACN Corporation Information
Table 75. VACN Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. VACN Main Product
Table 77. VACN Recent Development
Table 78. Changsheng Rabies Vaccine Corporation Information
Table 79. Changsheng Corporation Information
Table 80. Changsheng Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Changsheng Main Product
Table 82. Changsheng Recent Development
Table 83. BCHT Rabies Vaccine Corporation Information
Table 84. BCHT Corporation Information
Table 85. BCHT Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. BCHT Main Product
Table 87. BCHT Recent Development
Table 88. Hissen Rabies Vaccine Corporation Information
Table 89. Hissen Corporation Information
Table 90. Hissen Rabies Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Hissen Main Product
Table 92. Hissen Recent Development
Table 93. Sales Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Rabies Vaccine Distributors List
Table 96. Rabies Vaccine Customers List
Table 97. Market Key Trends
Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 99. Key Challenges
Table 100. Global Rabies Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 101. Global Rabies Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 102. Global Rabies Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 103. Global Rabies Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 104. Global Rabies Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 105. Global Rabies Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 106. Global Rabies Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 107. Global Rabies Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 108. Global Rabies Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Global Rabies Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Rabies Vaccine
Figure 2. Global Rabies Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Vero Cell Rabies Vaccine Product Picture
Figure 4. BHK Product Picture
Figure 5. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 6. Other Product Picture
Figure 7. Global Rabies Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 8. Pre-exposure Prophylaxis
Figure 9. Post-exposure Prophylaxis
Figure 10. Global Rabies Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Rabies Vaccine Sales Capacity (K Units) (2015-2026)
Figure 12. Global Rabies Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Rabies Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Rabies Vaccine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Rabies Vaccine Revenue in 2019
Figure 16. Rabies Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Rabies Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Rabies Vaccine Sales Market Share by Region in 2019
Figure 19. Global Rabies Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Rabies Vaccine Revenue Market Share by Region in 2019
Figure 21. North America Rabies Vaccine Sales Market Share by Country in 2019
Figure 22. North America Rabies Vaccine Revenue Market Share by Country in 2019
Figure 23. U.S. Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Rabies Vaccine Sales Market Share by Country in 2019
Figure 28. Europe Rabies Vaccine Revenue Market Share by Country in 2019
Figure 29. Germany Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Rabies Vaccine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Rabies Vaccine Revenue Market Share by Region in 2019
Figure 41. China Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Rabies Vaccine Sales Market Share by Country in 2019
Figure 64. Latin America Rabies Vaccine Revenue Market Share by Country in 2019
Figure 65. Mexico Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Rabies Vaccine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Rabies Vaccine Revenue Market Share by Country in 2019
Figure 73. Turkey Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Rabies Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Rabies Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Rabies Vaccine by Type (2015-2020)
Figure 80. Sales Market Share of Rabies Vaccine by Type in 2019
Figure 81. Revenue Share of Rabies Vaccine by Type (2015-2020)
Figure 82. Revenue Market Share of Rabies Vaccine by Type in 2019
Figure 83. Global Rabies Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Rabies Vaccine Sales Market Share by Application (2015-2020)
Figure 85. Global Rabies Vaccine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Rabies Vaccine by Application (2015-2020)
Figure 87. Global Revenue Share of Rabies Vaccine by Application in 2020
Figure 88. GSK (Novartis) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Sanofi-Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Chengda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Yisheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Prcmise Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. VACN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Changsheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. BCHT Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Hissen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Price Trend of Key Raw Materials
Figure 98. Manufacturing Cost Structure of Rabies Vaccine
Figure 99. Manufacturing Process Analysis of Rabies Vaccine
Figure 100. Rabies Vaccine Industrial Chain Analysis
Figure 101. Channels of Distribution
Figure 102. Distributors Profiles
Figure 103. Porter's Five Forces Analysis
Figure 104. North America Rabies Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 105. North America Rabies Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 106. Europe Rabies Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Rabies Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Latin America Rabies Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Rabies Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Middle East and Africa Rabies Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Rabies Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Asia Pacific Rabies Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Rabies Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
  • Global Metabolism Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Metabolism Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 18250 million by 2025, from USD 14970 million in 2019. The Metabolism Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landsca......
  • Global Levothyroxine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Levothyroxine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Levothyroxine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales ana......
  • Global Simethicone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 06-Jan-2020        Price: US 3480 Onwards        Pages: 104
    Summary Market Overview The global Simethicone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.3% in the forecast period of 2020 to 2025 and will expected to reach USD 31 million by 2025, from USD 29 million in 2019. The Simethicone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analys......
  • Global Drugs for Schistosomiasis Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Drugs for Schistosomiasis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 90 million by 2025, from USD 78 million in 2019. The Drugs for Schistosomiasis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competi......
  • Global Deferiprone Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 96
    Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload. The proportion of deferiprone tablet in 2016 is about 62.64%, while deferiprone capsule have a 26.76% market share.Deferiprone is widely applied in Transfusional Iron Overload and NTDT Caused Iron Overload.......
  • Global Deferasirox Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 92
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be take......
  • Global Legal Marijuana Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes c......
  • Global Flu Vaccine Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 119
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The classification of Flu Vaccine includes Who......
  • Global Rabies Vaccine Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 96
    Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years. Rabies vaccine is an irreplaceable product, so profile of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs